W

ASHINGTON — Rep. Elijah Cummings (D-Md.) has always been outspoken on the issue of drug pricing, even wrangling a meeting with President Trump in March to discuss how to reduce costs for Americans struggling with the cost of their prescriptions.

Cummings, who recently returned to Capitol Hill after recuperating from heart surgery, used a decidedly different medium — one preferred by the President — on Thursday in resurfacing the issue.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy